The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJust Group Regulatory News (JUST)

Share Price Information for Just Group (JUST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 101.40
Bid: 101.20
Ask: 101.60
Change: -1.60 (-1.55%)
Spread: 0.40 (0.395%)
Open: 102.80
High: 103.40
Low: 100.80
Prev. Close: 103.00
JUST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update statement on results of AGM

4 Dec 2019 14:01

RNS Number : 6937V
Just Group PLC
04 December 2019
 

 

 

 

 

 

NEWS RELEASE

www.justgroupplc.co.uk

4 December 2019

 

Update on 2019 Annual General Meeting ("AGM") resolution votes

In its 2019 AGM results announcement on 13 June 2019, the Just Group plc (the "Company" or the "Group") announced that all resolutions were passed. However, the total votes in favour of the following resolutions were below 80%:

·; Resolution 3: to re-elect Chris Gibson-Smith as a Director of the Company. Total votes received in favour were 72.34%.

·; Resolution 14: to renew the authority to allot shares. Total votes received in favour were 78.91%.

·; Resolution 16: to renew the authority to grant additional power to dis-apply pre-emption rights. Total votes received in favour were 76.34%.

Following the AGM, the Company proactively engaged with a significant number of shareholders, in accordance with provision 4 of the 2018 UK Corporate Governance Code. This included a series of meetings and calls with the Company's Senior Independent Director which were specifically targeted at those who voted against these resolutions to understand better the reasons behind their votes. Additional discussion on governance issues took place in meetings between shareholders and the Company's Chairman and Chief Executive Officer.

Taking each of the resolutions in turn:

Resolution 3

From the views expressed by shareholders, the level of votes against the Company's Chairman, Chris Gibson-Smith, was influenced by his role as chairman of the Group's Nomination Committee ("Nomination Committee") and the lack of appointment of female Non-Executive Directors ("NEDs") to improve the gender diversity of the Company's board of directors (the "Board").

The Board, including the Nomination Committee, acknowledges that it should be more diverse, and has prioritised improving its gender balance. During 2018, the Nomination Committee worked closely with a leading search firm to improve the diversity of the Board and identified three potential female candidates with a view to appointment to the Group and Life Company Boards. However, due to the uncertainty caused by the publication of the Prudential Regulation Authority's ("PRA") Consultation Paper 13/18, candidates withdrew from the process. As a result, the Group was regrettably not able to show progress in 2018 against the Hampton-Alexander Review's recommendations for FTSE 350 companies to improve the representation of women in leadership positions by 2020.

The Board and Nomination Committee remain committed to improving the diversity of the Board and have continued to engage actively in identifying potential female NEDs. The publication by the PRA of Policy Statement 31/18 on 10 December 2018 has allowed the Company to reengage in its search process in a context of reduced uncertainty. The Company notes that it has recently appointed Mary Kerrigan to the regulated boards of directors of Just Retirement Limited and Partnership Life Assurance Company Limited. The Board remains committed to achieving the Hampton-Alexander targets and has also set its own internal target that 33% of senior leadership roles should be held by women by 2023.

 

Resolutions 14 and 16

 

The Board understands that the primary reason why the Company received over 20% of votes against these resolutions was the use of a "cash-box" placing structure to raise equity capital earlier this year.

 

Having taken the advice of its financial advisors, the Board concluded that it was necessary and in the best interests of shareholders to raise equity and restricted tier 1 debt concurrently in order to manage the impact of Policy Statement 31/18. Given the need for simultaneous equity and debt issuance, the Board was advised and concluded that that equity could not be raised on a timely basis using a fully pre-emptive structure such as a rights issue, which would also have been more costly. The Group consulted a number of its largest shareholders on the proposed structure of the capital raising ahead of its announcement, and prioritised its existing shareholders when allocating shares.

 

The Board has a clear strategy in place to achieve capital self-sufficiency by 2022 and to de-risk the balance sheet. Although it has renewed its authorities for equity issuance, the Company has no intention of raising new equity capital over this period and acknowledges shareholder concerns in this area.

 

The Company will continue to engage with shareholders and will provide a further update, as appropriate, on this engagement in the Annual Report.

 

Enquiries

 

Investors / Analysts

 

James Pearce, Director of Group Finance

 

Telephone: +44 (0) 7715 085 099

james.pearce@wearejust.co.uk

 

Paul Kelly, Investor Relations Manager

Telephone: +44 (0) 20 7444 8127

paul.kelly@wearejust.co.uk

 

 

 

Media

 

Stephen Lowe, Group Communications Director

 

Telephone: +44 (0) 1737 827 301

press.office@wearejust.co.uk

 

Temple Bar Advisory

Alex Child-Villiers

William Barker

Telephone: +44 (0) 20 7002 1080

 

A copy of this announcement will be available on the Group's website www.justgroupplc.co.uk

 

JUST GROUP PLC

GROUP COMMUNICATIONS

Vale House, Roebuck Close

Bancroft Road, Reigate

Surrey RH2 7RU

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMUGGRAPUPBGWC
Date   Source Headline
25th Apr 202410:04 amRNSDirector/PDMR Shareholding
12th Apr 202410:00 amRNSDirector/PDMR Shareholding
2nd Apr 20245:20 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSHolding(s) in Company
26th Mar 20244:08 pmRNSHolding(s) in Company
26th Mar 20243:41 pmRNSAnnual Report and Accounts and Notice of AGM
8th Mar 20247:00 amRNSResults for the year ended 31 December 2023
7th Mar 20244:00 pmRNSHolding(s) in Company
6th Mar 20244:00 pmRNSHolding(s) in Company
4th Mar 20244:30 pmRNSHolding(s) in Company
5th Feb 20245:00 pmRNSHolding(s) in Company
31st Jan 20243:30 pmRNSHolding(s) in Company
26th Jan 20241:49 pmRNSHolding(s) in Company
25th Jan 20245:30 pmRNSDirector Declaration
22nd Jan 20244:43 pmRNSHolding(s) in Company
18th Jan 20244:55 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSBUSINESS UPDATE FOR YEAR ENDED 31 DECEMBER 2023
17th Jan 20244:12 pmRNSHolding(s) in Company
12th Jan 20243:01 pmRNSHolding(s) in Company
10th Jan 20241:31 pmRNSHolding(s) in Company
4th Jan 20244:25 pmRNSHolding(s) in Company
1st Dec 202311:32 amRNSBlock listing Interim Review
28th Nov 20233:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20233:04 pmRNSDirectorate Change
13th Oct 202310:41 amRNSDirectorate Change
28th Sep 202310:13 amRNSDirector/PDMR Shareholding
16th Aug 20232:04 pmRNSHolding(s) in Company
15th Aug 20237:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS ENDED 30/6/2023
20th Jul 20233:00 pmRNSHolding(s) in Company
18th Jul 20237:00 amRNSBusiness update for the six months to 30 June 2023
12th Jul 202310:34 amRNSDirectorate Change
11th Jul 20237:00 amRNSIFRS 17 FY 2022 and H1 22 restatement
6th Jul 20237:00 amRNSDirectorate Change
28th Jun 20239:36 amRNSHolding(s) in Company
1st Jun 202310:00 amRNSBlock listing Interim Review
25th May 20234:00 pmRNSHolding(s) in Company
9th May 20231:02 pmRNSResult of AGM
3rd May 20239:30 amRNSDirectorate Change
13th Apr 202312:05 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:05 pmRNSDirector/PDMR Shareholding
24th Mar 20234:50 pmRNSAnnual Financial Report and Notice of AGM
24th Mar 202311:06 amRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSResults for the year ended 31 December 2022
1st Mar 20231:08 pmRNSDirectorate Change
6th Feb 20237:00 amRNSIFRS 17 UPDATE
26th Jan 20237:00 amRNSBUSINESS UPDATE FOR THE YEAR ENDED 31 DEC 2022
5th Jan 202310:19 amRNSDirectorate Change
9th Dec 202212:15 pmRNSDirector/PDMR Shareholding
1st Dec 20221:32 pmRNSBlock listing Interim Review
11th Nov 202210:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.